FDA Approved: EPTIFIBATIDE — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for Eptifibatide from Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

SUPPL AP for EPTIFIBATIDE (EPTIFIBATIDE)